Series A+ · Biotech

MicroCyto completes ¥300 million Series A+ for AI biocomputing

Henan Investment Group Huirong Fund and Tan Ruiqing participated in the March financing.

MicroCyto announced a ¥300 million Series A+ financing on March 30, 2026, with participation from Henan Investment Group Huirong Fund and Tan Ruiqing.

The company plans to expand its AI biocomputing research and applications in biological manufacturing. Its PoseX collaboration platform evaluates molecular-docking approaches, supporting work on industrial enzymes and bio-based materials.

Use of funds

Develop AI biocomputing technology and expand applications in biological manufacturing.

Funding history

Series A+ · This roundCN¥300M
Equity financing~CN¥300M

Sources

  1. MicroCyto march financingchinaventure.com.cn · Mar 30, 2026